Adenosine A3 receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity

Neoplasia

Volumn 11, Issue 11, 2009, Pages 1132-1145

  Jajoo, Sarvesh ^a   Mukherjea, Debashree ^a   Watabe, Kounosuke ^a   Ramkumar, Vickram ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE A3 RECEPTOR; ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P47; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL MEMBRANE; CELL MIGRATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING;

EID: 70350716433     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09744     Document Type: Article

References (60)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, and Thun MJ (2008). Cancer statistics 2008. CA Cancer J Clin 58, 71-96.
2. Condeelis JS, Wyckoff JB, Bailly M, Pestell R, Lawrence D, Backer J, and Segall JE (2001). Lamellipodia in invasion. Semin Cancer Biol 11, 119-128.
3. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, and Horwitz AR (2003). Cell migration: integrating signals from front to back. Science 302, 1704-1709. (Pubitemid 37505725)
4. Lee TK, Man K, Ho JW, Wang XH, Poon RT, Sun CK, Ng KT, Ng IO, Xu R, and Fan ST (2005). Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target. Carcinogenesis 26, 681-687. (Pubitemid 41214160)
5. Bouzahzah B, Albanese C, Ahmed F, Pixley F, Lisanti MP, Segall JD, Condeelis J, Joyce D, Minden A, Der CJ, et al. (2001). Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med 7, 816-830. (Pubitemid 34175305)
6. Uhlenbrock K, Eberth A, Herbrand U, Daryab N, Stege P, Meier F, Friedl P, Collard JG, and Ahmadian MR (2004). The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism. J Cell Sci 117, 4863-4871. (Pubitemid 39433450)
7. Hall A (1992). Ras-related GTPases and the cytoskeleton. Mol Biol Cell 3, 475-479.
8. Haas A and Goebel W (1992). Microbial strategies to prevent oxygen-dependent killing by phagocytes. Free Radic Res Commun 16, 137-157.
9. Bedard K and Krause KH (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245-313. (Pubitemid 46209993)
10. Lassègue B and Clempus RE (2003). Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285, R277-R297. (Pubitemid 36898897)
11. Behrend L, Henderson G, and Zwacka RM (2003). Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31, 1441-1444. (Pubitemid 38030996)
12. Karin M, Takahashi T, Kapahi P, Delhase M, Chen Y, Makris C, Rothwarf D, Baud V, Natoli G, Guido F, et al. (2001). Oxidative stress and gene expression: the AP-1 and NF-kappaB connections. Biofactors 15, 87-89. (Pubitemid 34455067)
13. Ramkumar V, Hallam DM, and Nie Z (2001). Adenosine, oxidative stress and cytoprotection. Jpn J Pharmacol 86, 265-274.
14. Tey HB, Khoo HE, and Tan CH (1992). Adenosine modulates cell growth in human epidermoid carcinoma (A431) cells. Biochem Biophys Res Commun 187, 1486-1492.
15. Colquhoun A and Newsholme EA (1997). Inhibition of human tumour cell proliferation by analogues of adenosine. Cell Biochem Funct 15, 135-139. (Pubitemid 27344610)
16. Ryzhov S, Novitskiy SV, Zaynagetdinov R, Goldstein AE, Carbone DP, Biaggioni I, Dikov MM, and Feoktistov I (2008). Host A(2B) adenosine receptors promote carcinoma growth. Neoplasia 10, 987-995.
17. Madi L, Bar-Yehuda S, Barer F, Ardon E, Ochaion A, and Fishman P (2003). A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition. J Biol Chem 278, 42121-42130. (Pubitemid 37310479)
18. Ohana G, Bar-Yehuda S, Arich A, Madi L, Dreznick Z, Rath-Wolfson L, Silberman D, Slosman G, and Fishman P (2003). Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101. Br J Cancer 89, 1552-1558. (Pubitemid 37386614)
19. 3AR agonist. Anticancer Res 23, 2077-2083.
20. Fishman P, Bar-Yehuda S, Ohana G, Barer F, Ochaion A, Erlanger A, and Madi L (2004). An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B. Oncogene 23, 2465-2471. (Pubitemid 38520744)
21. Madi L, Ochaion A, Rath-Wolfson L, Bar-Yehuda S, Erlanger A, Ohana G, Harish A, Merimski O, Barer F, and Fishman P (2004). The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res 10, 4472-4479. (Pubitemid 38878891)
22. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Simioni C, Leung E, Maclennan S, Baraldi PG, and Borea PA (2007). Caffeine inhibits adenosineinduced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol 72, 395-406. (Pubitemid 47124120)
23. 3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Clin Cancer Res 10, 5895-5901.
24. Jajoo S, Mukherjea D, Pingle S, Sekino Y, and Ramkumar V (2006). Induction of adenosine A1 receptor expression by pertussis toxin via an adenosine 5′- diphosphate ribosylation-independent pathway. J Pharmacol Exp Ther 317, 1-10.
25. Puntambekar P, Mukherjea D, Jajoo S, and Ramkumar V (2005). Essential role of Rac1/NADPH oxidase in nerve growth factor induction of TRPV1 expression. J Neurochem 95, 1689-1703. (Pubitemid 41804065)
26. Dewas C, Fay M, Gougerot-Pocidalo MA, and El-Benna J (2000). The mitogenactivated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils. J Immunol 165, 5238-5244. (Pubitemid 30809456)
27. Hazan-Halevy I, Levy T, Wolak T, Lubarsky I, Levy R, and Paran E (2005). Stimulation of NADPH oxidase by angiotensin II in human neutrophils is mediated by ERK, p38 MAP-kinase and cytosolic phospholipase A2. J Hypertens 23, 1183-1190. (Pubitemid 40862722)
28. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, and Wasserman W (2000). Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol 362, 364-374. (Pubitemid 30822527)
29. Haslam RJ, Davidson MM, and Desjardins JV (1978). Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J 176, 83-95.
30. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, and Hidaka H (1990). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]- 5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265, 5267-5272. (Pubitemid 120014499)
31. DrögeW(2002). Free radicals in the physiological control of cell function. Physiol Rev 82, 47-95. (Pubitemid 34654215)
32. Ripple MO, Henry WF, Rago RP, and Wilding G (1997). Prooxidant- antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 89, 40-48.
33. Nelson WG, De Marzo AM, and Isaacs WB (2003). Prostate cancer. N Engl J Med 349, 366-381.
34. Sun XY, Donald SP, and Phang JM (2001). Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells. Carcinogenesis 22, 1775-1780. (Pubitemid 33064841)
35. Brar SS, Corbin Z, Kennedy TP, Hemendinger R, Thornton L, Bommarius B, Arnold RS, Whorton AR, Sturrock AB, Huecksteadt TP, et al. (2003). NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol 285, C353-C369. (Pubitemid 36917850)
36. Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, Chung L, Petros JA, and Arnold RS (2005). Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62, 200-207. (Pubitemid 40096784)
37. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, and Jiang BH (2007). Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 67, 10823-10830. (Pubitemid 350145911)
38. Martindale JL and Holbrook NJ (2002). Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192, 1-15.
39. Towatari M, Iida H, Tanimoto M, Iwata H, Hamaguchi M, and Saito H (1997). Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia 11, 479-484. (Pubitemid 27173933)
40. Sivaraman VS, Wang H, Nuovo GJ, and Malbon CC (1997). Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 99, 1478-1483. (Pubitemid 27163797)
41. Steinmetz R, Wagoner HA, Zeng P, Hammond JR, Hannon TS, Meyers JL, and Pescovitz OH (2004). Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol Endocrinol 18, 2570-2582. (Pubitemid 39335989)
42. Tsubaki M, Matsuoka H, Yamamoto C, Kato C, Ogaki M, Satou T, Itoh T, Kusunoki T, Tanimori Y, and Nishida S (2007). The protein kinase C inhibitor, H7, inhibits tumor cell invasion and metastasis in mouse melanoma via suppression of ERK1/2. Clin Exp Metastasis 24, 431-438. (Pubitemid 47367685)
43. Hao F, Tan M, Xu X, Han J, Miller DD, Tigyi G, and Cui MZ (2007). Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38α. Biochim Biophys Acta 1771, 883-892. (Pubitemid 46891301)
44. Calipel A, Mouriaux F, Glotin AL, Malecaze F, Faussat AM, and Mascarelli F (2006). Extracellular signal-regulated kinase-dependent proliferation is mediated through the protein kinase A/B-Raf pathway in human uveal melanoma cells. J Biol Chem 281, 9238-9250. (Pubitemid 43864639)
45. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, Maclennan S, and Borea PA (2005). A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells. J Biol Chem 280, 19516-19526. (Pubitemid 41379472)
46. 3 adenosine receptor activation. Cancer Biol Ther 7, 278-284.
47. Gessi S, Merighi S, Varani K, Cattabriga E, Benini A, Mirandola P, Leung E, MacLennan S, Feo C, Baraldi S, et al. (2007). Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype. J Cell Physiol 211, 826-836. (Pubitemid 46683050)
48. Schulte G and Fredholm BB (2002). Signaling pathway from the human adenosine A(3) receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2. Mol Pharmacol 62, 1137-1146. (Pubitemid 35222505)
49. Kim SG, Ravi G, Hoffmann C, Jung YJ, Kim M, Chen A, and Jacobson KA (2002). p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA. Biochem Pharmacol 63, 871-880. (Pubitemid 34243000)
50. Lu J, Pierron A, and Ravid K (2003). An adenosine analogue, IB-MECA, downregulates estrogen receptor alpha and suppresses human breast cancer cell proliferation. Cancer Res 63, 6413-6423. (Pubitemid 37255191)
51. Tan EY, Richard CL, Zhang H, Hoskin DW, and Blay J (2006). Adenosine downregulates DPPIVon HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway. Am J Physiol Cell Physiol 291, C433-C444. (Pubitemid 44343626)
52. Gonzalez FA, Raden DL, and Davis RJ (1991). Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinase. J Biol Chem 266, 22159-22163.
53. phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by proline-directed kinases. J Biol Chem 269, 23431-23436.
54. phox. DNA Seq 16, 65-68.
55. Mizuki K, Kadomatsu K, Hata K, Ito T, Fan QW, Kage Y, Fukumaki Y, Sakaki Y, Takeshige K, and Sumimoto H (1998). Functional modules and expression of mouse p40(phox) and p67(phox), SH3-domain-containing proteins involved in the phagocyte NADPH oxidase complex. Eur J Biochem 251, 573-582. (Pubitemid 28108949)
56. Grijelmo C, Rodrigue C, Svrcek M, Bruyneel E, Hendrix A, de Wever O, and Gespach C (2007). Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells. Cell Signal 19, 1722-1732. (Pubitemid 46935428)
57. Lyons LS, Rao S, Balkan W, Faysal J, Maiorino CA, and Burnstein KL (2008). Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer. Mol Endocrinol 22, 597-608.
58. Engers R, Ziegler S, Mueller M, Walter A, Willers R, and Gabbert HE (2007). Prognostic relevance of increased Rac GTPase expression in prostate carcinomas. Endocr Relat Cancer 14, 245-256. (Pubitemid 47242626)
59. O'Connor KL and Mercurio AM (2001). Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells. J BiolChem 276, 47895-47900. (Pubitemid 37370686)
60. Katz M, Amit I, and Yarden Y (2007). Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta 1773, 1161-1176. (Pubitemid 47125978)